Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SRZN

Surrozen (SRZN)

Surrozen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRZN
DateTimeSourceHeadlineSymbolCompany
04/03/20248:40AMGlobeNewswire Inc.Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary FibrosisNASDAQ:SRZNSurrozen Inc
04/01/20248:30AMGlobeNewswire Inc.Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043NASDAQ:SRZNSurrozen Inc
04/01/20248:30AMGlobeNewswire Inc.Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq RulesNASDAQ:SRZNSurrozen Inc
02/07/20246:16AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
02/07/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
01/22/20245:24PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
01/18/20248:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
01/18/20248:30AMGlobeNewswire Inc.Surrozen Provides Corporate Update on Clinical ProgramsNASDAQ:SRZNSurrozen Inc
12/18/20239:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRZNSurrozen Inc
12/13/20235:21PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
12/13/20235:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
12/11/20234:11PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
12/11/20234:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
11/08/20234:27PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
11/08/20234:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRZNSurrozen Inc
11/08/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
11/08/20234:05PMGlobeNewswire Inc.Surrozen Provides Third Quarter 2023 Financial ResultsNASDAQ:SRZNSurrozen Inc
10/24/20234:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRZNSurrozen Inc
10/24/20234:18PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRZNSurrozen Inc
10/13/20234:51PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SRZNSurrozen Inc
10/13/20234:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
08/23/20235:17PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRZNSurrozen Inc
08/09/20234:39PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
08/09/20234:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRZNSurrozen Inc
08/09/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
08/09/20234:05PMGlobeNewswire Inc.Surrozen Provides Second Quarter 2023 Financial ResultsNASDAQ:SRZNSurrozen Inc
07/19/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
07/05/20234:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
06/05/20238:30AMGlobeNewswire Inc.Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic StrokeNASDAQ:SRZNSurrozen Inc
05/22/20239:35AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRZNSurrozen Inc
 Showing the most relevant articles for your search:NASDAQ:SRZN